RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Kayyak Ventures
K

Kayyak Ventures portfolio

Kayyak Ventures has 1 portfolio company on record at Recent Funding.

Type: Venture capital.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Rounds led: 1 of 2.
Capital in their rounds: $38.7M.
Latest deal: AgendaPro · Aug 20, 2025.
About this page

It is a venture capital firm based in Santiago, CL. It led 1 of the 2 rounds it joined. Its most recent investment on record is AgendaPro's $35M Series B+ round in August 2025, alongside Riverwood Capital. That company is in Sales and marketing. It has co-invested with Riverwood Capital, Y Combinator and Cathexis Ventures.

About Kayyak Ventures

Firm type: Venture capital.
Headquarters: Santiago, CL.
Stages: Seed, Series A, Series B.
Sectors: Climate Tech, Consumer, Digital Health, Enterprise Software, Fintech, Impact & Social Good, SaaS, Sector Agnostic.
Leads rounds: Yes.
Portfolio companies: 29.
Exits: 0.
Rounds led: 5.

What Kayyak Ventures invests in

How Kayyak Ventures invests

StageDealsCapital in rounds
Series B+ 1 50%$35M
Series A 1 50%$3.7M
YearDealsCapital in rounds
2022 1 50%$3.7M
2025 1 50%$35M

Kayyak Ventures portfolio companies

CompanyRound with Kayyak VenturesTotal raisedLatest raise
AAgendaPro
Sales and marketing
Series B+ · $35M$38.7MAug 20, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Sales and marketing).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 2 rounds on Recent Funding that name Kayyak Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Kayyak Ventures, which is a subset of its real portfolio. API: /api/v1/investors/kayyak-ventures (get a free API key). More: the most active VC firms and new venture capital funds.